Institutional investors hold a majority ownership of PCRX through the 109.51% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended March 2018, these large investors purchased a net $481.7 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONSONANCE CAPITAL MANAGEMENT LP Bought 1.0 Million shares of Pacira Pharmaceuticals In...